Renaud La Joie

18.7k total citations · 3 hit papers
159 papers, 7.4k citations indexed

About

Renaud La Joie is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Renaud La Joie has authored 159 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Psychiatry and Mental health, 96 papers in Physiology and 71 papers in Cognitive Neuroscience. Recurrent topics in Renaud La Joie's work include Dementia and Cognitive Impairment Research (101 papers), Alzheimer's disease research and treatments (94 papers) and Functional Brain Connectivity Studies (53 papers). Renaud La Joie is often cited by papers focused on Dementia and Cognitive Impairment Research (101 papers), Alzheimer's disease research and treatments (94 papers) and Functional Brain Connectivity Studies (53 papers). Renaud La Joie collaborates with scholars based in United States, France and Sweden. Renaud La Joie's co-authors include Gaël Chételat, Gil D. Rabinovici, Francis Eustache, William J. Jagust, Audrey Perrotin, Béatrice Desgranges, Vincent de La Sayette, Brigitte Landeau, Florence Mézenge and Suzanne L. Baker and has published in prestigious journals such as Nature Medicine, Nature Communications and Neuron.

In The Last Decade

Renaud La Joie

147 papers receiving 7.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease

2017 475 citations Renaud La Joie, Joel H. Kramer et al. Brain profile →
Four distinct trajectories of tau deposition identified in Alzheimer’s disease

2021 400 citations Jacob W. Vogel, Alexandra L. Young et al. Nature Medicine profile →
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease

2021 154 citations Salvatore Spina, Renaud La Joie et al. Brain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renaud La Joie United States	47	3.7k	3.5k	3.2k	1.2k	1.1k	159	7.4k
Aaron P. Schultz United States	50	3.6k 1.0×	3.3k 0.9×	3.0k 0.9×	1.4k 1.1×	972 0.9×	157	7.0k
Suzanne L. Baker United States	44	4.5k 1.2×	4.9k 1.4×	3.7k 1.2×	1.7k 1.4×	1.1k 1.0×	135	8.6k
Michael Ewers Germany	51	3.9k 1.0×	3.7k 1.1×	2.8k 0.9×	1.6k 1.3×	1.9k 1.7×	147	8.8k
Elizabeth C. Mormino United States	52	5.0k 1.4×	4.5k 1.3×	3.5k 1.1×	1.5k 1.2×	1.1k 1.0×	154	8.6k
J. Alex Becker United States	33	3.4k 0.9×	3.1k 0.9×	2.8k 0.9×	1.2k 1.0×	748 0.7×	64	6.1k
Susan De Santi United States	49	4.3k 1.1×	4.3k 1.2×	2.7k 0.9×	1.5k 1.2×	1.5k 1.3×	110	9.8k
Robert Perneczky Germany	47	3.5k 0.9×	3.1k 0.9×	1.7k 0.5×	1.0k 0.8×	1.0k 0.9×	200	7.2k
Tuomo Hänninen Finland	47	4.6k 1.2×	3.7k 1.1×	2.2k 0.7×	732 0.6×	1.4k 1.2×	148	9.1k
Michel J. Grothe Germany	43	2.5k 0.7×	2.4k 0.7×	2.6k 0.8×	1.3k 1.1×	874 0.8×	171	5.9k
Eric Westman Sweden	56	4.1k 1.1×	3.5k 1.0×	3.0k 0.9×	1.9k 1.5×	1.8k 1.6×	288	9.5k

Countries citing papers authored by Renaud La Joie

Since Specialization

Citations

This map shows the geographic impact of Renaud La Joie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud La Joie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud La Joie more than expected).

Fields of papers citing papers by Renaud La Joie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud La Joie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud La Joie. The network helps show where Renaud La Joie may publish in the future.

Co-authorship network of co-authors of Renaud La Joie

This figure shows the co-authorship network connecting the top 25 collaborators of Renaud La Joie. A scholar is included among the top collaborators of Renaud La Joie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renaud La Joie. Renaud La Joie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wisse, Laura E.M., et al.. (2025). Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease. Alzheimer s & Dementia. 21(2). e14582–e14582. 8 indexed citations

Leuzy, Antoine, Ariane Bollack, Daniela Pellegrino, et al.. (2025). Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease. Alzheimer s & Dementia. 21(3). e14528–e14528. 9 indexed citations

Villanueva-Meyer, Javier, Winston Chiong, Courtney Lane‐Donovan, et al.. (2025). Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease. Neurology Clinical Practice. 15(4). e200508–e200508.

Joie, Renaud La, Jeffrey L. Cummings, Jeffrey L. Dage, et al.. (2025). Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies. Alzheimer s & Dementia. 21(11). e70997–e70997. 2 indexed citations

Hill‐Jarrett, Tanisha G., Scott C. Zimmerman, Michelle A. DeVost, et al.. (2024). Comparison of approaches to control for intracranial volume in research on the association of brain volumes with cognitive outcomes. Human Brain Mapping. 45(4). e26633–e26633. 12 indexed citations

Joie, Renaud La, Scott C. Zimmerman, M. Maria Glymour, et al.. (2024). Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants. Alzheimer s & Dementia. 20(3). 1978–1987. 6 indexed citations

Collij, Lyduine E., Ariane Bollack, Renaud La Joie, et al.. (2024). Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium. Alzheimer s & Dementia. 20(12). 9037–9048. 22 indexed citations

Leuzy, Antoine, Niklas Mattsson, Nicholas Cullen, et al.. (2023). Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes. Alzheimer s & Dementia. 19(7). 2994–3004. 16 indexed citations

Ranasinghe, Kamalini G., Parul Verma, Chang Cai, et al.. (2022). Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer’s disease. eLife. 11. 64 indexed citations

10.

Vogel, Jacob W., Alexandra L. Young, Neil P. Oxtoby, et al.. (2021). Four distinct trajectories of tau deposition identified in Alzheimer’s disease. Nature Medicine. 27(5). 871–881. 400 indexed citations breakdown →

11.

Strom, Amelia, Leonardo Iaccarino, Lauren Edwards, et al.. (2021). Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease. Brain. 145(2). 713–728. 56 indexed citations

12.

Asken, Breton M., William G. Mantyh, Renaud La Joie, et al.. (2021). Association of remote mild traumatic brain injury with cortical amyloid burden in clinically normal older adults. Brain Imaging and Behavior. 15(5). 2417–2425. 14 indexed citations

13.

Spina, Salvatore, Renaud La Joie, Cathrine Petersen, et al.. (2021). Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease. Brain. 144(7). 2186–2198. 154 indexed citations breakdown →

14.

Harrison, Theresa M., et al.. (2021). Fusiform Gyrus Phospho‐Tau is Associated with Failure of Proper Name Retrieval in Aging. Annals of Neurology. 90(6). 988–993. 6 indexed citations

15.

Elahi, Fanny M., Daniel J. Bennett, Samantha Walters, et al.. (2021). Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12181–e12181. 20 indexed citations

16.

Groot, Colin, B.T. Thomas Yeo, Jacob W. Vogel, et al.. (2020). Latent atrophy factors related to phenotypical variants of posterior cortical atrophy. Neurology. 95(12). e1672–e1685. 21 indexed citations

17.

Pereira, Joana B., Theresa M. Harrison, Renaud La Joie, Suzanne L. Baker, & William J. Jagust. (2020). Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging. 47(9). 2155–2164. 23 indexed citations

18.

Ashton, Nicholas J., Abdul Hye, Anto P. Rajkumar, et al.. (2020). An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nature Reviews Neurology. 16(5). 265–284. 125 indexed citations

19.

Ossenkoppele, Rik, Chul Hyoung Lyoo, Carole H. Sudre, et al.. (2019). Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease. Alzheimer s & Dementia. 16(2). 335–344. 77 indexed citations

20.

Joie, Renaud La, Audrey Perrotin, Vincent de La Sayette, et al.. (2013). Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia. NeuroImage Clinical. 3. 155–162. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact